Skip to content
StockMarketAgent
Healthcare / Diagnostics & ResearchUpdated 2026-05-10 22:07 UTC

PSNL stock hub

Personalis, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

PSNLis not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
626.2M
NASDAQ
Market data

Live price

Current market quote for this ticker.

Current price
PSNL
In the news

Latest news · PSNL

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a
P25 12.3P50 18.4P75 33.1
Trailing P/En/a
P25 14.9P50 23.2P75 38.5
ROE-41.4
P25 -105.6P50 -46.5P75 -3.1
ROIC-23.5
P25 -63.1P50 -27.3P75 0.5
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All PSNL market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
215
Groups with data
11
Currency
USD
Showing 215 of 215 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

25
MetricValue
Cik
0001527753
Company name
Personalis, Inc.
Country
United States
Country code
US
Cusip
71535D106
Employees
260
Employees Change
31%
Employees Change Percent
13.54
Enterprise value
$431.8M
Exchange
NASDAQ
Financial currency
USD
First seen
2026-05-09
Industry
Diagnostics & Research
IPO Date
2019-06-20
Isin
US71535D1063
Last refreshed
2026-05-10
Market cap
$626.2M
Market cap category
Small-Cap
Price
$5.98
Price currency
USD
Rev Per Employee
248,134.62x
Sector
Healthcare
Sic
8071
Symbol
PSNL
Website
https://www.personalis.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

7
MetricValue
Earnings Yield
-15.26%
EV Sales Forward
5.38x
EV/Sales
6.69x
FCF yield
-13.52%
P/B ratio
2.46x
P/S ratio
9.71x
PS Forward
7.8x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

19
MetricValue
EBIT Margin
-158.91%
EBITDA Margin
-143.68%
Gross margin
13.72%
Gross Profit
$8.9M
Gross Profit Growth
-68.99%
Gross Profit Growth Q
-96.1%
Gross Profit Growth3 Y
-13.77%
Gross Profit Growth5 Y
-17.74%
Net Income
$-95.6M
Net Income Growth Years
3%
Pretax Margin
-148.06%
Profit Margin
-148.11%
Profit Per Employee
$-367,508
ROA
-21.41
Roa5y
-18.47
ROCE
-35.8
ROE
-41.35
Roe5y
-42.99
ROIC
-23.47

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

9
MetricValue
Cagr1y
23.57%
Cagr3y
38.71%
Cagr5y
-23.45%
EPS Growth Years
3
Revenue Growth
-24.72x
Revenue Growth Q
-24.91x
Revenue Growth Years
0x
Revenue Growth3 Y
-2.06x
Revenue Growth5 Y
-4.3x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

19
MetricValue
Asset Turnover
$0.22
Assets
$325.4M
Cash
$233.2M
Current Assets
$258.2M
Current Liabilities
$39M
Debt
$38.8M
Debt Equity
$0.15
Equity
$254.8M
Interest Coverage
-457.7
Liabilities
$70.6M
Long Term Assets
$67.2M
Long Term Liabilities
$31.6M
Net Cash
$194.4M
Net Cash By Market Cap
$31.05
Net Cash Growth
38.43%
Net Debt Equity
$-0.76
Tangible Book Value
$254.8M
Tangible Book Value Per Share
$2.43
WACC
14.21

Liquidity

Current-asset coverage and working-capital efficiency metrics.

6
MetricValue
Current ratio
6.61
Inventory Turnover
11.76
Net Working Capital
$-6.3M
Quick ratio
6.31
Working Capital
$219.2M
Working Capital Turnover
$0.33

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

2
MetricValue
Buyback Yield
-36.49%
Dividend Yield
0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

40
MetricValue
1Y total return
23.55%
200-day SMA
7.49
3Y total return
166.96%
50-day SMA
6.8
50-day SMA vs 200-day SMA
50under200
5Y total return
-73.71%
All Time High
53.46
All Time High Change
-88.81%
All Time High Date
2021-01-20
All Time Low
0.89
All Time Low Change
571.46%
All Time Low Date
2023-11-10
ATR
0.51
Beta
1.97
Beta1y
0.99
Beta2y
1.12
Ch YTD
-24.87
High
6.07
High52
11.5
High52 Date
2026-01-22
High52ch
-48%
Low
5.42
Low52
3.84
Low52 Date
2025-08-06
Low52ch
55.73%
Ma50ch
-12.07%
Premarket Change Percent
-6.18
Premarket Price
$5.62
Premarket Volume
52,175
Price vs 200-day SMA
-20.15%
RSI
46.58
RSI Monthly
49.47
RSI Weekly
42.25
Sharpe ratio
0.63x
Sortino ratio
1.03
Total Return
-36.49%
Tr YTD
-24.87
Tr1m
-3.08%
Tr1w
3.46%
Tr3m
-25.76%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

13
MetricValue
Analyst Count
5
Analyst Count Top
1
Analyst Price Target Top
$13
Analyst Ratings
Strong Buy
Analyst Ratings Top
Strong Buy
Earnings EPS Estimate
$-0.27
Earnings Revenue Estimate
14,466,000x
Earnings Revenue Estimate Growth
-29.79x
Operating Income
$-102.5M
Operating margin
-158.9
Price target
$12.2
Price Target Change
$104
Price Target Change Top
$117

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

11
MetricValue
Float
68,195,642%
Float Percent
65.12%
Net Borrowing
-5,097,000
Shares Insiders
1.18%
Shares Institutions
56.2%
Shares Out
104,721,098
Shares Qo Q
12.91%
Shares Yo Y
36.49%
Short Float
18.17%
Short Ratio
8.35
Short Shares
11.84

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

64
MetricValue
Adjusted FCF
$-94.4M
Average Volume
2,110,735.95x
Bv Per Share
2.43
CAPEX
$-5.2M
Ch1m
-3.08
Ch1w
3.46
Ch1y
23.55
Ch3m
-25.76
Ch3y
167
Ch5y
-73.71
Ch6m
-13.71
Change
-0.17%
Change From Open
4.91
Close
5.99
Days Gap
-4.84
Depreciation Amortization
9,830,000
Dollar Volume
16,306,114.5
Earnings Date
2026-05-07
Earnings Time
amc
EBIT
$-102.5M
EBITDA
$-92.7M
EPS
$-1.02
F Score
1
FCF
$-84.6M
FCF EV Yield
-19.6x
FCF Per Share
$-0.81
Financing CF
128,081,000
Fiscal Year End
December
Founded
2,011
Income Tax
$30,000
Investing CF
-46,038,000
Ipr
-64.82
Iprfo
-74.77
Is Primary Listing
1
Is Spac
No
Last Earnings Date
2026-05-07
Last Report Date
2026-03-31
Last Split Type
Never
Last10k Filing Date
2026-02-26
Ma150
8.18
Ma150ch
-26.87%
Ma20
6.06
Ma20ch
-1.32%
Net CF
2,593,000
Next Earnings Date
2026-08-04
Open
5.7
Optionable
Yes
Position In Range
86.15
Post Close
5.98
Postmarket Change Percent
1.76
Postmarket Price
$6.09
Ppne
63,395,000
Pre Close
5.99
Price Date
2026-05-08
Ptbv Ratio
2.46
Relative Volume
1.29x
Revenue
64,515,000x
SBC By Revenue
15.13x
Share Based Comp
9,763,000
Tax By Revenue
0.05x
Tr6m
-13.71%
Us State
California
Volume
2,726,775
Z Score
2.4
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does PSNL pay a dividend?

Capital-return profile for this ticker.

Performance

PSNL stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
+23.6%
S&P 500 1Y: n/a
3Y total return
+167.0%
S&P 500 3Y: n/a
5Y total return
-73.7%
S&P 500 5Y: n/a
10Y total return
n/a
S&P 500 10Y: n/a
Ownership

Who owns PSNL?

Insider, institutional, and short-interest positioning.

Institutional ownership
+56.2%
Float: +65.1% of shares outstanding
Insider ownership
+1.2%
Stake held by company insiders. Higher generally signals alignment.
Short interest
+18.2%
8.3 days to cover
Y/Y dilution
+36.5%
Negative means the company is buying back shares.
Technical

PSNL momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
46.6
Neutral momentum band
Price vs 200-day MA
-20.1%
50/200-day relationship not available
Beta (5Y)
1.97
More volatile than the market
Sharpe ratio
0.63
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About PSNL

Hub-level FAQ points readers to the deeper analysis pages.

What is the current PSNL stock rating?

Personalis, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full PSNL analysis?

The full report lives at /stocks/PSNL/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for PSNL?

The latest report frames PSNL around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the PSNL page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.